Evidence map›Paper›PMID 42321805›Full record

ArticleMalaria journal2026

Facility readiness and determinants of malaria test-before-treat implementation in public health facilities in Kaduna and Kano States, Nigeria.

Uchenna Igbokwe, Zaharaddeen Babandi, Precious Uahomo, Yayo Abdulsalami Manu, Babangida Musa, Sule Danga, Hamza Muhammad, Fatima Mohammed Musa, Zainab Kwaru Muhammad-Idris, Idowu Akanmu and 11 more

Abstract read
In one paragraph

Article in Malaria journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Uchenna IgbokweSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Zaharaddeen BabandiSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Precious UahomoSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria. precious.uahomo@solinagroup.com.
Yayo Abdulsalami ManuCentre for Infectious Diseases Research (CIDR), Bayero University, Kano, Kano State, Nigeria.
Babangida MusaState Malaria Elimination Program (SMEP), Kano, Kano State, Nigeria.
Sule DangaState Malaria Elimination Program (SMEP), Kaduna, Kaduna State, Nigeria.
Hamza MuhammadCentre for Infectious Diseases Research (CIDR), Bayero University, Kano, Kano State, Nigeria.
Fatima Mohammed MusaCentre for Mosquito-Borne Diseases Research and Community Health (CEMCOH), Kaduna State University, Kaduna, Kaduna State, Nigeria.
Zainab Kwaru Muhammad-IdrisCentre for Mosquito-Borne Diseases Research and Community Health (CEMCOH), Kaduna State University, Kaduna, Kaduna State, Nigeria.
Idowu AkanmuSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Shukrat Yusuff-LawalSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Osezefe EhimenSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Miftahu YahayaSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Nchelem IchegboSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Olalekan OjosipeSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Joseph NatsahSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Reuben KahaSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Tisan GugongSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Saheed PopoolaSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Oluwaseun FadeyiSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.
Eric AigbogunSolina Centre for International Development and Research (SCIDaR), 8 Libreville Street, Off Aminu Kano Crescent, Wuse II, Abuja, FCT, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrompt diagnosis and treatment of malaria remain central to malaria control strategies. The World Health Organization recommends testing suspected malaria cases before treatment using rapid diagnostic tests (RDTs) or microscopy. However, evidence on the readiness of health facilities to implement this policy in high-burden Nigerian states remains limited. This study assessed facility readiness, testing-before-treatment (TBT) coverage, and facility-level determinants of malaria diagnostic readiness among public health facilities in Kaduna and Kano States, Nigeria.

methodsA cross-sectional health facility assessment was conducted across 418 public health facilities in Kaduna and Kano States between August 5 and 28, 2025. A stratified two-stage sampling approach was used, with primary health facilities randomly selected proportionally across all 67 Local Government Areas and all secondary facilities purposively included. Data were collected using a structured Health Facility Assessment questionnaire. Facility readiness was assessed using five indicators: availability of RDTs, availability of microscopy services, trained staff on malaria case management, availability of standard operating procedures, and absence of stock-outs of RDTs or artemisinin-based combination therapy within the previous three months. A composite readiness index (0-5) was constructed and facilities were classified as having full or partial readiness. Associations between facility characteristics and readiness were examined using multivariable logistic regression.

resultsAll facilities had RDTs and trained staff on malaria case management, and none reported commodity stock-outs during the three-month reference period. Overall, 381 facilities (91.1%) demonstrated full readiness, with a mean readiness score of 4.91 ± 0.29. Microscopy services were available in 23.0% of facilities. Most facilities reported high TBT coverage, with 90.4% reporting ≥ 85% testing coverage. Secondary facilities (aOR = 2.15, 95% CI:1.06-4.36), urban location (aOR = 1.78, 95% CI:1.01-3.12), supportive supervision (aOR = 2.54, 95% CI:1.28-5.02), malaria focal persons (aOR = 2.92, 95% CI:1.63-5.23), and availability of free malaria commodities (aOR = 1.98, 95% CI:1.07-3.68) were significantly associated with full readiness.

conclusionPublic health facilities assessed in Kaduna and Kano States demonstrated high structural readiness for malaria diagnosis. Study limitations include the cross-sectional design, reliance on facility records which may be subject to reporting bias, and the exclusion of private health facilities, limiting generalizability. These findings highlight the need for sustained commodity security, regular supportive supervision, and targeted investments in rural facilities to maintain and strengthen diagnostic readiness.

Indexed as

Health FacilitiesMalariaCross-Sectional StudiesHumansMicroscopyNigeriaRapid Diagnostic TestsdeterminantsKaduna stateKano statemalariaPublic health facilityrapid diagnostic testsreadinesssubnational tailoring (SNT)test-before-treat

Identifiers

PMID42321805
PMCPMC13536742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.